Tenoxicam Market In Global
Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) that acts as a COX inhibitor. ... Read More
Pimecrolimus is a natural ascomycin macrolactam that binds to macrophilin-12 and inhibits calcineurin as well as prolyl isomerase.
This report contains market size and forecasts of Pimecrolimus in global, including the following market information:
Global Pimecrolimus Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pimecrolimus Market Sales, 2017-2022, 2023-2028, (Kg)
Global top five Pimecrolimus companies in 2021 (%)
The global Pimecrolimus market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Min Purity Less Than 98% Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pimecrolimus include Cayman Chemical, BioVision, Santa Cruz Biotechnology, Merck, AbMole, Selleck Chemicals, Key Organics, BOC Sciences and Biosynth Carbosynth, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Pimecrolimus manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pimecrolimus Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pimecrolimus Market Segment Percentages, by Type, 2021 (%)
Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%
Global Pimecrolimus Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pimecrolimus Market Segment Percentages, by Application, 2021 (%)
Research
Medical
Global Pimecrolimus Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kg)
Global Pimecrolimus Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pimecrolimus revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pimecrolimus revenues share in global market, 2021 (%)
Key companies Pimecrolimus sales in global market, 2017-2022 (Estimated), (Kg)
Key companies Pimecrolimus sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cayman Chemical
BioVision
Santa Cruz Biotechnology
Merck
AbMole
Selleck Chemicals
Key Organics
BOC Sciences
Biosynth Carbosynth
Adooq Bioscience
AG Scientific
TOKU-E
Alfa Chemistry
LKT Laboratories
Aladdin
Tenoxicam is a non-steroidal anti-inflammatory drug (NSAID) that acts as a COX inhibitor. ... Read More
Demethylzeylasteral, the active component isolated from Tripterygium wilfordii Hook F., inhibits ... Read More
Bendazac is an anticataract drug. It has been reported that Bendazac acts by preventing protein d ... Read More
Royal Jelly Acid is an inhibitor of VEGF-induced angiogenesis, cell migration and proliferation& ... Read More